|
|
 |
|
Viewing report
|
|
|
|
Japan Pharma Company Outlook to 2016
Datamonitor, Nov 2011, Pages: 43
This analysis examines the outlook for companies in the Japan Pharma peer set. The report encompasses insight into key strategic themes across the group of companies and identifies sales trends using 6-year prescription pharmaceutical sales forecasts for all the companies covered.
Features and benefits
- Gain insight into Japan Pharma companies strategic outlook across the next 6 years
- Analyze sales forecasts by company, therapy area, lifecycle stage, and molecule type.
Highlights
Strategic insight into the prospects for Japan Pharma companies over the next six years. Picking out key trends across the companies and comparing performance using a variety of cuts of forecast sales.
Your key questions answered
- Benchmark companies outlook against key rivals across the Japan Pharma peer set
- Assess how M&A has played an intgeral role in driving historical growth of the Japanese peer set, and how M&A will remain strategically important
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
